Skip to content 
Celexo® Refine Bubble Toner
PHA and BHA Exfoliation Technology Powered by Exosome Science
Effective skin preparation requires more than surface cleansing. Celexo® Refine Bubble Toner, developed by ABio Materials Co. in pharmaceutical-grade facilities in Korea, delivers a dual-acid exfoliation system combining Polyhydroxy Acid at 1% and Beta Hydroxy Acid at 0.1%, enriched with the proprietary Exo-Cica complex. Positioned as Pre Care Step 2 in the Celexo® Exo-Therapy Skincare Protocol, this bubble-action toner works to open absorption pathways, refine the epidermal layer, and condition the complexion for optimal booster uptake. This page examines the scientific mechanisms, clinical applications, and evidence-based benefits of Celexo® Refine Bubble Toner.
The Science of
Celexo® Refine Bubble Toner
Polyhydroxy Acid Exfoliation
This toner is formulated with PHA at 1%, a next-generation hydroxy acid known for its large molecular weight and gentle exfoliating properties. Unlike its alpha-hydroxy acid counterparts, PHA penetrates the epidermal layer gradually, loosening intercellular bonds between dead surface cells without disrupting the underlying barrier. This measured dissolution supports effective renewal across a range of complexion types, including those with heightened sensitivity or recent procedural history.
Beta Hydroxy Acid Pathway Opening
Alongside PHA, the formulation incorporates BHA at 0.1%, a lipid-soluble acid that penetrates beyond the outermost epidermal layer and into the pore lining. This oil-affinity characteristic makes BHA particularly effective at clearing sebum-bound debris and loosening congestion within follicular channels. The combined action of PHA and BHA creates a comprehensively prepared complexion, addressing both surface texture and deeper pore congestion simultaneously.
Together, they establish the open channels the Main Booster phase requires for maximum penetration efficacy.
Exo-Cica Calming Integration
The Celexo® Exo-Therapy line centers on the principle that active treatment and biological support should work in parallel. In this step, Exo-Cica, the brand’s proprietary plant-derived exosome complex, delivers concurrent anti-inflammatory and soothing effects during exfoliation. By introducing calming cellular signals while exfoliants work, the formulation is designed to minimize reactive sensitization and support epidermal comfort before the primary treatment step.
Bubble-Action Delivery Mechanism
The effervescent format of this toner is more than an aesthetic feature. The effervescent micro-action provides gentle mechanical agitation at the skin surface, helping loosen and lift residual debris while distributing the acid complex evenly across the skin. This delivery mechanism helps ensure consistent contact between the exfoliating actives and the epidermal layer, supporting uniform surface renewal across uneven or textured areas.
Key Benefits of Celexo® Refine Bubble Toner
Dual-Acid Exfoliation System
PHA at 1% and BHA at 0.1% address surface-texture irregularities and follicular congestion for a more refined complexion.
Open Absorption Pathways
Designed to loosen intercellular bonds and clear pore channels, potentially improving uptake of the Celexo® Exo-Therapy booster actives that follow.
Integrated Exosome Soothing
Exo-Cica delivers concurrent calming support during exfoliation, helping maintain epidermal comfort throughout Pre Care Step 2.
Bubble-Action Distribution
The effervescent format distributes the acid complex evenly for consistent contact and uniform refinement across varying skin textures.
Barrier-Conscious Formulation
PHA’s larger molecular size limits penetration depth, making this formulation appropriate before professional procedures requiring maintained epidermal integrity.
Protocol-Optimized Design
As a continuation of Pre Care Step 1, it completes the preparatory phase prior to the Main Booster application.
Clinical Applications
This preparatory step is intended for professional treatment settings where thorough pre-procedural preparation is required, particularly ahead of device-assisted booster delivery or energy-based aesthetic procedures.
Common Use Cases:
Pre-booster preparation for microneedling, MTS, and radiofrequency treatments requires open absorption channels for active ingredient delivery.
Secondary exfoliation following Celexo® Enzyme Powder Wash, completing the Pre Care phase before Main Booster application.
Follicular congestion management for complexion types prone to sebum buildup or enlarged pores that may impede booster penetration.
Sensitive exfoliation for individuals requiring acid-based refinement who cannot tolerate higher-concentration formulations.
Transition step in the Celexo® Exo-Therapy Skincare Protocol, ensuring the epidermal surface is fully conditioned before booster actives are applied.
Application Protocol
Skin Preparation:
Ensure the face has been cleansed with Celexo® Enzyme Powder Wash as Pre Care Step 1 and is free of residue before application.
Application Method:
Dispense onto a cotton pad or palm, then apply evenly across the face with gentle sweeping motions, allowing the effervescent formula to activate on contact.
Duration:
Allow it to remain for the appropriate contact period. The acid actives and Exo-Cica complex continue working during this time.
Removal and Transition:
No rinsing is required. Allow the formula to absorb fully. Once the effervescent activity subsides, the complexion is ready for the next step.
Frequency:
Apply before each session, ahead of the Main Booster phase. Frequency is determined by the treating practitioner based on individual assessment.
Post-Application Care:
Proceed to the Main Booster step, selecting from Celexo® 30000 Booster and Solution Ampoule, Celexo® Exo-Cica, or Celexo® Black Label based on the targeted concern.
PHA and BHA Technology and Safety
Polyhydroxy Acids and Beta Hydroxy Acids are two established chemical exfoliation families. PHA is valued for its antioxidant co-benefits and lower incidence of sensitization due to its larger molecular size. BHA’s lipid solubility extends the refinement benefit into the follicular environment, addressing congestion that surface-only acids cannot reach.
At these concentrations, both acids are calibrated for pre-treatment preparation in accordance with a professional protocol. Exo-Cica ensures that calming biological signals are present from the earliest stage of treatment, supporting a tolerance-conscious approach.
Formulation Science and Quality Standards
Celexo® Refine Bubble Toner is manufactured at ABio Materials Co. facilities in Korea under ISO 13485 and GMP certification. Each batch is evaluated for PHA and BHA concentration, Exo-Cica integrity, effervescent stability, microbiological safety per USP protocols, pH calibration, and packaging integrity.
This standard ensures reliable preparatory performance with every application.
Frequently Asked Questions
What active ingredients does Celexo® Refine Bubble Toner contain?
How does Celexo® Refine Bubble Toner fit into the Skincare Protocol?
What is the difference between PHA and BHA exfoliation?
Is Celexo® Refine Bubble Toner suitable for sensitive complexion types?
Where is Celexo® Refine Bubble Toner manufactured?
How can I obtain Celexo® Refine Bubble Toner?
Opening the Pathway for Precision Exosome Delivery
Celexo® Refine Bubble Toner represents the final step of the Celexo® Exo-Therapy Pre Care phase, where dual-acid science and exosome technology work together to bring the complexion to its optimal state of readiness. By addressing both surface refinement and follicular clearance before any booster is introduced, ABio Materials Co. ensures that every subsequent stage of the protocol is delivered to a thoroughly prepared, receptive surface.
To learn more about Celexo® Refine Bubble Toner or explore the full Celexo® Exo-Therapy line, visit a-biousa.com.
Contact Us
We welcome inquiries from partners, distributors, and industry professionals worldwide. Whether you are interested in our product portfolio, ODM/OEM collaboration, or research support, our team is committed to providing clear, timely, and knowledgeable assistance. Reach out to learn how our bio-material technologies and exosome expertise can support your clinical, aesthetic, or research goals.
Get in touch
